Cargando…
Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
BACKGROUND: Though outcome models have been proposed previously, it is unknown whether cutoffs in clinical pregnancy and live birth rates at all ages are able to classify in vitro fertilization (IVF) patients into good-, intermediate- and poor prognosis. METHODS: We here in 3 infertile patient cohor...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901433/ https://www.ncbi.nlm.nih.gov/pubmed/27286817 http://dx.doi.org/10.1186/s12967-016-0924-7 |
_version_ | 1782436804233789440 |
---|---|
author | Gleicher, Norbert Kushnir, Vitaly A. Sen, Aritro Darmon, Sarah K. Weghofer, Andrea Wu, Yan-Guang Wang, Qi Zhang, Lin Albertini, David F. Barad, David H. |
author_facet | Gleicher, Norbert Kushnir, Vitaly A. Sen, Aritro Darmon, Sarah K. Weghofer, Andrea Wu, Yan-Guang Wang, Qi Zhang, Lin Albertini, David F. Barad, David H. |
author_sort | Gleicher, Norbert |
collection | PubMed |
description | BACKGROUND: Though outcome models have been proposed previously, it is unknown whether cutoffs in clinical pregnancy and live birth rates at all ages are able to classify in vitro fertilization (IVF) patients into good-, intermediate- and poor prognosis. METHODS: We here in 3 infertile patient cohorts, involving 1247, 1514 and 632 women, built logistic regression models based on 3 functional ovarian reserve (FOR) parameters, including (1) number of good quality embryos, (2) follicle stimulating hormone (FSH, mIU/mL) and (3) anti-Müllerian hormone (AMH, ng/mL), determining whether clinical pregnancy and live birth rates can discriminate between good, intermediate and poor prognosis patients. RESULTS: All models, indeed, allowed at all ages for separation by prognosis, though cut offs changed with age. In the embryo model, increasing embryo production resulted in linear improvement of IVF outcomes despite transfer of similar embryo numbers; in the FSH model outcomes and FSH levels related inversely, while the association of AMH followed a bell-shaped polynomial pattern, demonstrating “best” outcomes at mid-ranges. All 3 models demonstrated increasingly poor outcomes with advancing ages, though “best” AMH even above age 43 was still associated with unexpectedly good pregnancy and delivery outcomes. Excessively high AMH, in contrast, was at all ages associated with spiking miscarriage rates. CONCLUSIONS: At varying peripheral serum concentrations, AMH, thus, demonstrates hithero unknown and contradictory effects on IVF outcomes, deserving at different concentrations investigation as a potential therapeutic agent, with pregnancy-supporting and pregnancy-interrupting properties. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0924-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4901433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49014332016-06-11 Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH Gleicher, Norbert Kushnir, Vitaly A. Sen, Aritro Darmon, Sarah K. Weghofer, Andrea Wu, Yan-Guang Wang, Qi Zhang, Lin Albertini, David F. Barad, David H. J Transl Med Research BACKGROUND: Though outcome models have been proposed previously, it is unknown whether cutoffs in clinical pregnancy and live birth rates at all ages are able to classify in vitro fertilization (IVF) patients into good-, intermediate- and poor prognosis. METHODS: We here in 3 infertile patient cohorts, involving 1247, 1514 and 632 women, built logistic regression models based on 3 functional ovarian reserve (FOR) parameters, including (1) number of good quality embryos, (2) follicle stimulating hormone (FSH, mIU/mL) and (3) anti-Müllerian hormone (AMH, ng/mL), determining whether clinical pregnancy and live birth rates can discriminate between good, intermediate and poor prognosis patients. RESULTS: All models, indeed, allowed at all ages for separation by prognosis, though cut offs changed with age. In the embryo model, increasing embryo production resulted in linear improvement of IVF outcomes despite transfer of similar embryo numbers; in the FSH model outcomes and FSH levels related inversely, while the association of AMH followed a bell-shaped polynomial pattern, demonstrating “best” outcomes at mid-ranges. All 3 models demonstrated increasingly poor outcomes with advancing ages, though “best” AMH even above age 43 was still associated with unexpectedly good pregnancy and delivery outcomes. Excessively high AMH, in contrast, was at all ages associated with spiking miscarriage rates. CONCLUSIONS: At varying peripheral serum concentrations, AMH, thus, demonstrates hithero unknown and contradictory effects on IVF outcomes, deserving at different concentrations investigation as a potential therapeutic agent, with pregnancy-supporting and pregnancy-interrupting properties. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0924-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-10 /pmc/articles/PMC4901433/ /pubmed/27286817 http://dx.doi.org/10.1186/s12967-016-0924-7 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Gleicher, Norbert Kushnir, Vitaly A. Sen, Aritro Darmon, Sarah K. Weghofer, Andrea Wu, Yan-Guang Wang, Qi Zhang, Lin Albertini, David F. Barad, David H. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH |
title | Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH |
title_full | Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH |
title_fullStr | Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH |
title_full_unstemmed | Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH |
title_short | Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH |
title_sort | definition by fsh, amh and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown ivf outcome-determining factor associated with amh |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901433/ https://www.ncbi.nlm.nih.gov/pubmed/27286817 http://dx.doi.org/10.1186/s12967-016-0924-7 |
work_keys_str_mv | AT gleichernorbert definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT kushnirvitalya definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT senaritro definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT darmonsarahk definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT weghoferandrea definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT wuyanguang definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT wangqi definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT zhanglin definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT albertinidavidf definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh AT baraddavidh definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh |